FAKTOR-OPTIONSSCHEIN - AMGEN | Market Closed - Börse Stuttgart 18:52:22 03/07/2024 BST | ||
| 18.92 EUR | -3.42% |
|
| Current month | -5.12% | ||
| 1 month | +0.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 03/07/24 | 18.92 | -3.42% |
| 02/07/24 | 19.59 | +0.31% |
| 01/07/24 | 19.53 | -2.06% |
| 28/06/24 | 19.94 | -0.60% |
| 27/06/24 | 20.06 | -0.25% |
Delayed Quote Börse Stuttgart
Last update July 03, 2024 at 06:52 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | MC2RS6 |
| ISIN | DE000MC2RS60 |
| Date issued | 17/07/2019 |
| Strike | 207.2 $ |
| Maturity | Unlimited |
| Parity | 4.96 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 25.36 € |
|---|---|
| Lowest since issue | 8.12 € |
| Spread | 0.4 € |
| Spread % | 2.06% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.4
USD
Spread / Average Target
+2.28%
- Stock Market
- Certificates
- Certificat
